Operator of a specialty pharmaceutical company intended to develop proprietary ion-exchange resin formulations, prescription cough medicines and a pipeline of orphan drugs. The company's patented formulation acts as a passive drug formulation system to reduce the risk of prescription drug overdose irrespective of the number of tablets or capsules ingested, enabling medical professionals to treat bronchiectasis easily and patients to get relief from respiration-related diseases quickly.